We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$47.8B
AUM Growth
-$2.34B
(-4.7%)
Cap. Flow
-$5.56B
Cap. Flow
% of AUM
-11.64%
Top 10 Holdings %
Top 10 Hldgs %
32.03%
Holding
2,131
New
54
Increased
334
Reduced
1,616
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thomson Reuters
TRI
|
+$89.7M |
| 2 |
Fortinet
FTNT
|
+$69.3M |
| 3 |
Flowers Foods
FLO
|
+$37.9M |
| 4 |
Brown & Brown
BRO
|
+$28.6M |
| 5 |
Consolidated Edison
ED
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$626M |
| 2 |
Microsoft
MSFT
|
+$454M |
| 3 |
Apple
AAPL
|
+$414M |
| 4 |
Broadcom
AVGO
|
+$317M |
| 5 |
Amazon
AMZN
|
+$270M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Consumer Discretionary | 10.23% |
| 3 | Industrials | 9.49% |
| 4 | Communication Services | 9.26% |
| 5 | Financials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Custom Truck One Source
CTOS
$2.47B
| $66.2K | ﹤0.01% |
10,308
-2,052
| -17% | -$11.9K |
|
1902
Portillo's
PTLO
$315M
| $65.4K | ﹤0.01% |
10,145
-1,429
| -12% | -$12.1K |
|
1903
Altimmune
ALT
$539M
| $64.4K | ﹤0.01% |
17,081
-1,817
| -10% | -$7.02K |
|
1904
Cullinan Oncology
CGEM
$1.05B
| $64.2K | ﹤0.01% |
10,828
-1,837
| -15% | -$13.5K |
|
1905
Frontier Group Holdings
ULCC
$1.34B
| $63.9K | ﹤0.01% |
14,476
-2,884
| -17% | -$13.1K |
|
1906
Butterfly Network
BFLY
$1.72B
| $63.4K | ﹤0.01% |
32,844
-6,543
| -17% | -$11.1K |
|
1907
Coty
COTY
$2.33B
| $63K | ﹤0.01% |
15,584
-663
| -4% | -$3.04K |
|
|
ACH
1908
Accendra Health
ACH
$240M
| $61.9K | ﹤0.01% |
12,895
-3,900
| -23% | -$24.8K |
|
1909
Annexon
ANNX
$855M
| $61.9K | ﹤0.01% |
20,288
-3,444
| -15% | -$8.55K |
|
1910
Replimune Group
REPL
$814M
| $61.2K | ﹤0.01% |
14,611
-1,772
| -11% | -$11.3K |
|
1911
Editas Medicine
EDIT
$399M
| $61.2K | ﹤0.01% |
17,633
-2,799
| -14% | -$7.81K |
|
1912
Ribbon Communications
RBBN
$354M
| $61.1K | ﹤0.01% |
16,067
-3,169
| -16% | -$12.5K |
|
1913
Oil States International
OIS
$522M
| $60.7K | ﹤0.01% |
10,011
-1,996
| -17% | -$10.9K |
|
1914
Magnachip Semiconductor
MX
$128M
| $60.6K | ﹤0.01% |
19,361
+1,004
| +5% | +$3.4K |
|
1915
ARKO Corp
ARKO
$890M
| $60.1K | ﹤0.01% |
13,142
-2,618
| -17% | -$12.4K |
|
1916
Rocket Pharmaceuticals
RCKT
$348M
| $59.8K | ﹤0.01% |
18,335
-2,887
| -14% | -$9.09K |
|
1917
Acco Brands
ACCO
$369M
| $59.6K | ﹤0.01% |
14,944
-2,978
| -17% | -$11.6K |
|
1918
Compass Therapeutics
CMPX
$373M
| $59.5K | ﹤0.01% |
17,004
-1,791
| -10% | -$5.66K |
|
1919
The Honest Company
HNST
$417M
| $58.8K | ﹤0.01% |
15,967
-3,182
| -17% | -$13.5K |
|
1920
iHeartMedia
IHRT
$535M
| $58.5K | ﹤0.01% |
20,391
-4,062
| -17% | -$8.97K |
|
1921
B&G Foods
BGS
$285M
| $58.5K | ﹤0.01% |
13,195
-4,077
| -24% | -$17.8K |
|
1922
Vanda Pharmaceuticals
VNDA
$312M
| $58K | ﹤0.01% |
11,631
-1,994
| -15% | -$9.23K |
|
|
SRTA
1923
Strata Critical Medical Inc
SRTA
$436M
| $56.2K | ﹤0.01% |
11,111
-2,039
| -16% | -$9.01K |
|
|
CMRC
1924
Commerce.com Inc Series 1
CMRC
$224M
| $56.1K | ﹤0.01% |
11,242
-2,241
| -17% | -$10.8K |
|
1925
Omeros
OMER
$709M
| $55.5K | ﹤0.01% |
13,534
-226
| -2% | -$897 |
|
Similar funds
ProShare Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, ProShare Advisors held 2,131 positions worth $47.8B, down 4.7% from $50.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors withdrew a net $5.56B in Q3 2025, closing 126 positions and reducing 1,616 holdings. Its most notable exit was Ansys, an estimated $48.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, ProShare Advisors opened a new position in Thomson Reuters worth $75.8M.
- ProShare Advisors's largest Q3 2025 buy was Thomson Reuters: 480,707 shares worth $75.8M.
- ProShare Advisors added most to Fortinet in Q3 2025, an estimated $69.3M increase.
- ProShare Advisors's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $626M.
- ProShare Advisors fully exited Ansys in Q3 2025, selling an estimated $48.7M.
- ProShare Advisors's ten largest holdings make up 32% of its $47.8B portfolio in Q3 2025.
- ProShare Advisors opened 54 new positions and closed 126 in Q3 2025.
- ProShare Advisors's portfolio value fell 4.7% quarter-over-quarter to $47.8B.
Based on ProShare Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.